Increased expression and activation of cytosolic phospholipase A 2 in the spinal cord of patients with sporadic amyotrophic lateral sclerosis

Acta Neuropathologica

Volumn 119, Issue 3, 2010, Pages 345-354

  Shibata, Noriyuki ^a   Kakita, Akiyoshi ^b   Takahashi, Hitoshi ^b   Ihara, Yuetsu ^c   Nobukuni, Keigo ^c   Fujimura, Harutoshi ^d   Sakoda, Saburo ^e   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Minami Okayama Medical Center   (Japan)

^d TONEYAMA NATIONAL HOSPITAL   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Arachidonate; Glial activation; Inflammation; Motor neuron death; Oxidative stress; Phospholipase A 2; Plasma membrane injury

Indexed keywords

PHOSPHOLIPASE A2;

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; DENSITOMETRY; DISEASE DURATION; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MICROGLIA; MOTONEURON; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SPINAL CORD;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES; ASTROCYTES; AUTOPSY; BLOTTING, WESTERN; CYTOSOL; DENSITOMETRY; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; MOTOR NEURONS; PHOSPHOLIPASES A2; PHOSPHORYLATION; SPINAL CORD;

EID: 77953021561     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0636-7     Document Type: Article

References (50)

1. Almer G, Guégan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S (2001) Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49:176-185.
2. Appel SH, Beers D, Siklos L, Engelhardt JI, Mosier DR (2001) Calcium: the Darth Vader of ALS. Amyotroph Lateral Scler 2(Suppl 1):S47-S54.
3. Balsinde J, Balboa MA, Insel PA, Dennis EA (1999) Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 39:175-189.
4. Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762:1051-1067.
5. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, Sapirstein A (1997) Reduced fertility and postischemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390:622-625.
6. Bosetti F, Weerasinghe GR (2003) The expression of brain cyclooxygenase-2 is down-regulated in the cytosolic phospholipase A2 knockout mouse. J Neurochem 87:1471-1477.
7. Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ (2008) Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Curr Med Chem 15:1863-1869.
8. Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, Rothstein JD (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 52:771-778.
9. Goodall EF, Morison KE (2006) Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev Mol Med 8:1-22.
10. Hernández M, Bayón Y, Crespo MS, Nieto ML (1999) Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factora: phosphorylation of cytosolic phospholipase A2 and transactivation of cyclooxygenase-2. J Neurochem 73:1641-1649.
11. 2. J Biol Chem 274:5163-5169.
12. Ilzecka J (2003) Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients. Acta Neurol Scand 108:125-129. (Pubitemid 36920662)
13. 2 phosphorylation, translocation, proteolysis and activation by tumor necrosis factor-receptor subtypes. Biochem J 374:453-461.
14. 2 with COX-2 and the effect of non-steroidal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 93:403-411.
15. Kiaei M, Kipiani K, Calingasan NY, Wille E, Chen J, Heissig B, Rafii S, Lorenzl S, Beal MF (2007) Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 205:74-81.
16. Klegeris A, McGeer PL (2002) Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging 23:787-794.
17. Klivenyl P, Kiaei M, Gardian G, Calingasan NY, Beal MF (2004) Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 88:576-582.
18. 2 are resistant to MPTP neurotoxicity. J Neurochem 71:2634-2637.
19. 2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-b peptide. FASEB J 19:85-87.
20. 2 enzymes. Prostaglandins Other Lipid Mediat 68-69:3-58.
21. Lamb RE, Goldstein BJ (2008) Modulating an oxidativeinflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. Int J Clin Pract 62:1087-1095.
22. Lazarewicz JW, Wroblewski JT, Costa E (1990) N-Methyl-Daspartate- sensitive glutamate receptors induce calcium-mediated arachidonic acid release in primary cultures of cerebellar granule cells. J Neurochem 55:1875-1881.
23. Locatelli F, Corti S, Papadimitriou D, Fortunato F, Del Bo R, Donadoni C, Nizzardo M, Nardini M, Salani S, Ghezzi S, Strazzer S, Bresolin N, Comi GP (2007) Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice. Ann Neurol 62:81-92.
24. 2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett 379:77-81.
25. 2: a necessary step in long-term potentiation? Proc Natl Acad Sci USA 88:1893-1897.
26. McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459-470.
27. Miller B, Sarantis M, Traynelis SF, Attwell D (1992) Potentiation of NMDA receptor currents by arachidonic acid. Nature 355:722-725.
28. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem 274:3103-3105.
29. Paris D, Town T, Mullan M (2000) Novel strategies for apposing murine microglial activation. Neurosci Lett 278:5-8.
30. Penzo D, Petronilli V, Angelin A, Cusan C, Colonna R, Scorrano L, Pagano F, Prato M, Di Lisa F, Bernardi P (2004) Arachidonic acid released by phospholipase A2 activation triggers Ca2+- dependent apoptosis through the mitochondrial pathway. J Biol Chem 279:25219-25225.
31. Phillis JW, O'Regan MH (2004) A potentially critical role of phospholipases in the central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res Rev 44:13-47.
32. Raoul C, Buhler E, Sadeghi C, Jacquier A, Aebischer P, Pettmann B, Henderson CE, Haase G (2006) Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc Natl Acad Sci USA 103:6007-6012.
33. 2 stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured hippocampal cells. J Neurobiol 41:221-229.
34. Sapan CV, Lundblad RL, Price NC (1999) Colorimetric protein assay techniques. Biotechnol Appl Biochem 29:99-108.
35. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P (2001) Arachidonic acid causes cell death through the mitochondrial permeability transition. J Biol Chem 276:12035-12040.
36. Shibata N, Kawaguchi-Niida M, Yamamoto T, Toi S, Hirano A, Kobayashi M (2008) Effects of the PPARγ activator pioglitazone on p38 MAP kinase and IκBα in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis. Neuropathology 28:387-398.
37. Shibata N, Kakita, Takahashi H, Ihara Y, Nobukuni K, Fujimura H, Sakoda S, Sasaki S, Iwata M, Morikawa S, Hirano A, Kobayashi M (2009) Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients. Neurodegener Dis 6:118-126.
38. Stella N, Tence M, Glowinski J, Premont J (1994) Glutamateevoked release of arachidonic acid from mouse brain astrocytes. J Neurosci 14:568-575.
39. 2 is induced in reactive glia following different forms of neurodegeneration. Glia 27:110-128.
40. 2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 45:205-213.
41. 2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neurochem 103:1-16.
42. 2 activity is induced by CD95 ligand-linking in the mouse derived Sertoli cell line TM4 and is required to trigger apoptosis in CD95 bearing cells. Cell Death Differ 7:916-924.
43. 2 in allergic response and parturition. Nature 390:618-622.
44. Van Damme P, Robberecht W (2009) Recent advances in motor neuron disease. Curr Opin Neurol 22:486-492.
45. Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W (2006) The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1068-1082.
46. Veglianese P, Lo Coco D, Bao Cutrona M, Magnoni R, Pennacchini D, Pozzi B, Gowing G, Julien JP, Tortarolo M, Bendotti C (2006) Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS. Mol Cell Neurosci 31:218-231.
47. West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita SP, Hamdheydari L, Mai T, Mou S, Pye QN, Stewart C, West S, Williamson KS, Zemlan F, Hensley K (2004) The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor α activation of microglia and extends survival of G93A-SOD1 transgenic mice. J Neurochem 91:133-143.
48. Wu D-C, Bèrangére Ré D, Nagai M, Ischiropoulos H, Przedborski S (2006) The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci USA 103:12132-12137.
49. phox. J Biol Chem 277:25385-25392.
50. 2 mediate amyloid-β peptide-induced mitochondrial dysfunction. J Neurosci 26:11111-11119.